Cargando…
Noninvasive Assessment of Liver Fibrosis: Current and Future Clinical and Molecular Perspectives
Liver fibrosis is one of the risk factors for hepatocellular carcinoma (HCC) development. The staging of liver fibrosis can be evaluated only via a liver biopsy, which is an invasive procedure. Noninvasive methods for the diagnosis of liver fibrosis can be divided into morphological tests such as el...
Autores principales: | Masuzaki, Ryota, Kanda, Tatsuo, Sasaki, Reina, Matsumoto, Naoki, Ogawa, Masahiro, Matsuoka, Shunichi, Karp, Seth J., Moriyama, Mitsuhiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402287/ https://www.ncbi.nlm.nih.gov/pubmed/32664553 http://dx.doi.org/10.3390/ijms21144906 |
Ejemplares similares
-
Different Mechanisms of Action of Regorafenib and Lenvatinib on Toll-Like Receptor-Signaling Pathways in Human Hepatoma Cell Lines
por: Sasaki, Reina, et al.
Publicado: (2020) -
Cell Culture Systems and Drug Targets for Hepatitis A Virus Infection
por: Kanda, Tatsuo, et al.
Publicado: (2020) -
Suppressors of Cytokine Signaling and Hepatocellular Carcinoma
por: Masuzaki, Ryota, et al.
Publicado: (2022) -
Knockdown of Mitogen-Activated Protein Kinase Kinase 3 Negatively Regulates Hepatitis A Virus Replication
por: Kanda, Tatsuo, et al.
Publicado: (2021) -
Co-Occurrence of Hepatitis A Infection and Chronic Liver Disease
por: Kanda, Tatsuo, et al.
Publicado: (2020)